Board Meeting30 Mar 2026, 10:30 am
Brawn Biotech Ltd Closes Trading Window from 01st April 2026 till 48 hours after Q4 & FY26 Results
AI Summary
Brawn Biotech Ltd has announced the closure of the Trading Window for Designated Persons and their immediate relatives from 01st April 2026 till 48 hours after the declaration of Audited financial results for the quarter and financial year ended 31st March 2026. This decision is in accordance with the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015. Insiders are advised not to deal in securities of the Company during the closure of the Trading Window. The date of the Board meeting for result declaration will be intimated in due course.
Key Highlights
- Brawn Biotech Ltd closes Trading Window from 01st April 2026 till 48 hours after Q4 & FY26 results
- Closure in accordance with the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders
- Trading Window closure effective from 01 April 2026 till 48 hours after the declaration of Audited financial results for Q4 & FY26
- Insiders advised not to deal in securities of the Company during the closure of the Trading Window
- Date of Board meeting for result declaration to be intimated later
Price Impact
More from BRAWN